Schlusskurs
Andere Börsenplätze
|
||
- ILa | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 49 | 02.03.21 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 01.01.07 |
Chief Tech/Sci/R&D Officer | - | 01.01.22 | |
Shai Ashkenazi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Elad Mark
COO | Chief Operating Officer | 42 | 01.01.18 |
Shimon Hassin
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 01.01.04 | |
Investor Relations Contact | - | 01.12.15 | |
Human Resources Officer | - | 01.01.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Adi Raviv
BRD | Director/Board Member | 69 | 24.03.20 |
Samuel Moed
BRD | Director/Board Member | 62 | 24.03.20 |
Morris Laster
BRD | Director/Board Member | 59 | 27.11.17 |
Mark Germain
CHM | Chairman | 75 | 28.06.18 |
Yael Margolin
BRD | Director/Board Member | 70 | 01.01.19 |
Avner Rotman
BRD | Director/Board Member | 80 | 27.03.05 |
Amir Reichman
CEO | Chief Executive Officer | 49 | 02.03.21 |
Jay Green
BRD | Director/Board Member | 52 | 27.12.21 |
Unternehmenskontakt
Scinai Immunotherapeutics Ltd.
Jerusalem BioPark Hadassah Ein Kerem Campus
74036, Jerusalem
+972 8 930 2529
http://www.biondvax.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+2.01% | 42.59 Mrd. | |
+8.48% | 40.65 Mrd. | |
+49.22% | 40.57 Mrd. | |
-12.36% | 26.77 Mrd. | |
+8.88% | 24.81 Mrd. | |
-24.27% | 18.17 Mrd. | |
+28.83% | 12.05 Mrd. | |
-2.95% | 11.7 Mrd. | |
+6.91% | 11.1 Mrd. |